## Answer
(model generated chain of thought explanation)

First, let's identify the underlying condition that the 9-year-old boy is suffering from. The symptoms such as fever, productive cough, severe dyspnea, digital clubbing, and cyanosis, along with chronic interstitial changes on chest X-rays, hyperinflation of the lungs, and a decreased FEV1/FVC ratio, are indicative of Cystic Fibrosis (CF). CF is a genetic disorder that affects the respiratory, digestive, and reproductive systems.

Given that the goal of gene therapy for this boy's condition is to reintroduce the gene for which he is defective, we need to identify a suitable vector for the selective introduction of the replacement gene into the human body. The replacement gene for CF is the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene.

The most commonly used vectors for gene therapy in CF are:

- Adenovirus: This virus can be engineered to express the CFTR protein, making it a popular choice for CF gene therapy.
- Human Immunodeficiency Virus-1 (HIV-1): While HIV-1 is a powerful vector for gene therapy, its use in CF is limited due to concerns about immune rejection and the potential for viral replication.
- Coxsackie A virus: This virus has been used as a vector for gene therapy in some studies, but it is not commonly used for CF.

Considering these options, Adenovirus (A) would be the best choice for providing gene therapy for this boy's respiratory symptoms. Adenoviruses are widely used in gene therapy due to their ability to infect a wide range of cell types and express high levels of transgene expression.

The final answer is: A